Position in INCY
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$11,269,834
-$1,328,970 QoQ
Shares Held
119,739
-6.1% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vestcor Inc holds $67,387,677 across 32 Biotechnology names. INCY ranks #2 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
34,019 | $15,190,844 | |
| 2 | INCY |
Incyte Corp
This page
|
119,739 | $11,269,834 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
|
447,412 | $6,469,577 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
63,077 | $6,134,238 | |
| 5 | EXEL |
Exelixis, Inc.
|
138,065 | $5,921,607 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
100,000 | $5,272,000 | |
| 7 | ACLX |
Arcellx, Inc.
|
19,578 | $2,247,945 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,319 | $1,759,897 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,269,834 | 119,739 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $12,598,804 | 127,557 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $9,909,709 | 116,846 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $516,947 | 7,591 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $159,549 | 2,635 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $180,756 | 2,617 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $173,512 | 2,625 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $1,199,791 | 19,792 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,444,799 | 78,020 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $5,394,854 | 85,919 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,965,966 | 85,961 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,192,521 | 83,414 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $6,233,070 | 86,247 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,602,384 | 82,201 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $3,787,684 | 56,838 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,207,446 | 55,383 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,545,093 | 32,046 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $259,028 | 3,529 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $282,892 | 4,113 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $377,238 | 4,484 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $391,396 | 4,816 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $425,767 | 4,895 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $457,674 | 5,100 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $536,173 | 5,157 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $280,324 | 3,828 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||